These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10868900)

  • 1. Antiviral chemotherapy for the treatment of hepatitis B virus infections.
    Torresi J; Locarnini S
    Gastroenterology; 2000 Feb; 118(2 Suppl 1):S83-103. PubMed ID: 10868900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleoside analogues for chronic hepatitis B: antiviral efficacy and viral resistance.
    Papatheodoridis GV; Dimou E; Papadimitropoulos V
    Am J Gastroenterol; 2002 Jul; 97(7):1618-28. PubMed ID: 12135009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chronic hepatitis B.
    Yuen MF; Lai CL
    Lancet Infect Dis; 2001 Nov; 1(4):232-41. PubMed ID: 11871510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical aspects of lamivudine and famciclovir against hepatitis B virus.
    Shaw T; Locarnini SA
    J Viral Hepat; 1999 Mar; 6(2):89-106. PubMed ID: 10607220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agents in clinical development for the treatment of chronic hepatitis B.
    Raney AK; Hamatake RK; Hong Z
    Expert Opin Investig Drugs; 2003 Aug; 12(8):1281-95. PubMed ID: 12882617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic hepatitis B: Evolution over two decades.
    Yuen MF; Lai CL
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():138-43. PubMed ID: 21199525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus: old, new and future approaches to antiviral treatment.
    Karayiannis P
    J Antimicrob Chemother; 2003 Apr; 51(4):761-85. PubMed ID: 12654750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
    Delaney WE; Locarnini S; Shaw T
    Antivir Chem Chemother; 2001 Jan; 12(1):1-35. PubMed ID: 11437320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving therapies for the treatment of chronic hepatitis B virus infection.
    Delaney W; Bartholomeusz A; Locarnini SA
    Expert Opin Investig Drugs; 2002 Feb; 11(2):169-87. PubMed ID: 11829711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of chronic hepatitis B.
    Cornberg M; Jaroszewicz J; Manns MP; Wedemeyer H
    Minerva Gastroenterol Dietol; 2010 Dec; 56(4):451-65. PubMed ID: 21139543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical potential of emerging new agents in hepatitis B.
    Farrell GC
    Drugs; 2000 Oct; 60(4):701-10. PubMed ID: 11085196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: Nucleoside analogues for the treatment of chronic hepatitis B.
    Younger HM; Bathgate AJ; Hayes PC
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1211-30. PubMed ID: 15606384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral treatment for chronic hepatitis B virus infection--immune modulation or viral suppression?
    Buster EH; Janssen HL
    Neth J Med; 2006 Jun; 64(6):175-85. PubMed ID: 16788215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug insight: Nucleoside and nucleotide analog inhibitors for hepatitis B.
    Fung SK; Lok AS
    Nat Clin Pract Gastroenterol Hepatol; 2004 Dec; 1(2):90-7. PubMed ID: 16265070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Entecavir: a new nucleoside analogue for the treatment of chronic hepatitis B.
    Rivkin A
    Drugs Today (Barc); 2007 Apr; 43(4):201-20. PubMed ID: 17460784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of HBV therapy on the incidence of hepatocellular carcinoma.
    Triolo M; Della Corte C; Colombo M
    Liver Int; 2014 Feb; 34 Suppl 1():139-45. PubMed ID: 24373091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct notch signaling expression patterns between nucleoside and nucleotide analogues treatment for hepatitis B virus infection.
    Wang Z; Kawaguchi K; Honda M; Sakai Y; Yamashita T; Mizukoshi E; Kaneko S
    Biochem Biophys Res Commun; 2018 Jun; 501(3):682-687. PubMed ID: 29752943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adefovir dipivoxil: a review of its use in chronic hepatitis B.
    Dando T; Plosker G
    Drugs; 2003; 63(20):2215-34. PubMed ID: 14498759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral treatment of chronic hepatitis B virus infections: the past, the present and the future.
    Férir G; Kaptein S; Neyts J; De Clercq E
    Rev Med Virol; 2008; 18(1):19-34. PubMed ID: 17966115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral therapy in patients with chronic hepatitis B and cirrhosis.
    Lai CJ; Terrault NA
    Gastroenterol Clin North Am; 2004 Sep; 33(3):629-54, x-xi. PubMed ID: 15324948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.